Global Benign Prostatic Hyperplasia (BPH) Drugs Market Study 2016-2026, by Segment (Alpha-blocker, Phosphodiesterase Type-5 Inhibitors, … …), by Market (Hospitals, Clinics, … …), by Company (Astellas Pharma, Eli Lilly, … …)

Table of Content

1 Industry Overview

• 1.1 Benign Prostatic Hyperplasia (BPH) Drugs Industry
  • 1.1.1 Overview
  • 1.1.2 Products of Major Companies
• 1.2 Market Segment
  • 1.2.1 Industry Chain
  • 1.2.2 Consumer Distribution
• 1.3 Price & Cost Overview

2 Benign Prostatic Hyperplasia (BPH) Drugs Market by Type

• 2.1 By Type
  • 2.1.1 Alpha-blocker
  • 2.1.2 Phosphodiesterase Type-5 Inhibitors
  • 2.1.3 5-alpha-Reductase Inhibitors
• 2.2 Market Size by Type
• 2.3 Market Forecast by Type

3 Global Market Demand

• 3.1 Segment Overview
  • 3.1.1 Hospitals
  • 3.1.2 Clinics
  • 3.1.3 Others
• 3.2 Market Size by Demand
• 3.3 Market Forecast by Demand

4 Major Region Market

• 4.1 Global Market Overview
  • 4.1.1 Market Size & Growth
  • 4.1.2 Market Forecast
• 4.2 Major Region
  • 4.2.1 Market Size & Growth
  • 4.2.2 Market Forecast

5 Major Companies List

• 5.1 Astellas Pharma (Company Profile, Sales Data etc.)
• 5.2 Eli Lilly (Company Profile, Sales Data etc.)
• 5.3 GlaxoSmithKline (Company Profile, Sales Data etc.)
• 5.4 Sanofi (Company Profile, Sales Data etc.)
• 5.5 ADC Therapeutics (Company Profile, Sales Data etc.)
• 5.6 Bayer HealthCare (Company Profile, Sales Data etc.)
• 5.7 Bristol-Myers Squibb (Company Profile, Sales Data etc.)
• 5.8 Valeant Pharmaceuticals (Company Profile, Sales Data etc.)
• 5.9 Endo Pharmaceuticals (Company Profile, Sales Data etc.)
• 5.10 Foresee Pharmaceuticals (Company Profile, Sales Data etc.)
• 5.11 Madrigal Pharmaceuticals (Company Profile, Sales Data etc.)
• 5.12 Merck (Company Profile, Sales Data etc.)
• 5.13 Novartis (Company Profile, Sales Data etc.)
• 5.14 Spectrum Pharmaceuticals (Company Profile, Sales Data etc.)
• 5.15 Takeda Pharmaceuticals (Company Profile, Sales Data etc.)
• 5.16 Teva (Company Profile, Sales Data etc.)
• 5.17 Advaxis (Company Profile, Sales Data etc.)
• 5.18 ANI Pharmaceuticals (Company Profile, Sales Data etc.)
• 5.19 BHR Pharma (Company Profile, Sales Data etc.)

6 Conclusion

List of Tables

List of Table

Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market 2016-2019, by Type, in USD Million

Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market 2016-2019, by Type, in Volume

Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast 2020-2026, by Type, in USD Million

Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast 2020-2026, by Type, in Volume

Table Global Benign Prostatic Hyperplasia (BPH) Drugs Demand 2016-2019, in USD Million

Table Global Benign Prostatic Hyperplasia (BPH) Drugs Demand 2016-2019, in Volume

Table Global Benign Prostatic Hyperplasia (BPH) Drugs Demand Forecast 2020-2026, in USD Million

Table Global Benign Prostatic Hyperplasia (BPH) Drugs Demand Forecast 2020-2026, in Volume

Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market Size & Growth 2016-2019, in USD Million

Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market Size & Growth 2016-2019, in Volume

Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast 2020-2026, in USD Million

Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast 2020-2026, in Volume

Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market 2016-2019, by Region, in USD Million

Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market 2016-2019, by Region, in Volume

Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast 2020-2026, by Region, in USD Million

Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast 2020-2026, by Region, in Volume

Table Astellas Pharma Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Astellas Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Astellas Pharma Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Astellas Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Eli Lilly Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table GlaxoSmithKline Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Sanofi Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table ADC Therapeutics Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of ADC Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Bayer HealthCare Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Bayer HealthCare (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Bristol-Myers Squibb Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Valeant Pharmaceuticals Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Valeant Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Endo Pharmaceuticals Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Endo Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Foresee Pharmaceuticals Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Foresee Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Madrigal Pharmaceuticals Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Madrigal Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Merck Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Novartis Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Spectrum Pharmaceuticals Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Spectrum Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Takeda Pharmaceuticals Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Takeda Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Teva Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Advaxis Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Advaxis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table ANI Pharmaceuticals Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of ANI Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table BHR Pharma Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of BHR Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

List of Figures

List of Figure

Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Market Growth 2016-2019, by Type, in USD Million

Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Market Growth 2016-2019, by Type, in Volume